ExploreWatchlistsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total cash & short-term investments

SANTEN PHARMACEUTICAL CO.,LTD. (4536)

Market cap
¥606.1B
P/E ratio
17.3x
Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 202593,994-1.02%
Mar 31, 202494,961+61.84%
Mar 31, 202358,677-30.40%
Mar 31, 202284,307+32.94%
Mar 31, 202163,415-30.98%
Mar 31, 202091,882+29.30%
Mar 31, 201971,063+77.43%
Mar 31, 201840,051+22.21%
Mar 31, 201732,772-60.55%
Mar 31, 201683,078+69.15%
Mar 31, 201549,114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat